Bisalkaloid derivatives of dicarboxylic acids on the basis of lupinine, anabasine, and cytisine as reversible cholinesterase inhibitors.
Rozengart
E V
EV
Sechenov Institute of Evolution, Physiology, and Biochemistry, Russian Academy of Sciences, pr. Morisa Toreza 44, St. Petersburg, 194223 Russia.
D000470:Alkaloids / Q000737:chemistry*; D000691:Anabasine / Q000737:chemistry*; D000818:Animals; D001392:Azocines / Q000737:chemistry*; D002091:Butyrylcholinesterase / Q000737:chemistry; D002800:Cholinesterase Inhibitors / Q000737:chemistry*; D002802:Cholinesterases / Q000737:chemistry*; D003998:Dicarboxylic Acids / Q000737:chemistry*; D004789:Enzyme Activation; D004791:Enzyme Inhibitors; D004795:Enzyme Stability; D004912:Erythrocytes / Q000737:chemistry / Q000201:enzymology; D006736:Horses; D006801:Humans; D011807:Quinolizines / Q000737:chemistry*; D013034:Sparteine / Q000031:analogs & derivatives* / Q000737:chemistry*; D013237:Stereoisomerism; D000093843:Quinolizidine Alkaloids
D000470:Alkaloids; D000691:Anabasine; D001392:Azocines; D002091:Butyrylcholinesterase; D002800:Cholinesterase Inhibitors; D002802:Cholinesterases; D003998:Dicarboxylic Acids; D004791:Enzyme Inhibitors; D011807:Quinolizines; D013034:Sparteine; C015971:lupinine; D000093843:Quinolizidine Alkaloids; C004712:cytisine